Tirzepatide (5mg x10)

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in Australian preclinical research for its effects on insulin secretion dynamics, gastric emptying, and energy expenditure pathways. Australian laboratories investigate dual incretin receptor agonism in controlled metabolic research models — making Tirzepatide one of the most sought-after research peptides in our catalogue.

No. Tirzepatide sold by Bulk Aussie Peptides is strictly for laboratory research purposes only. It is not intended for human consumption, therapeutic application, or diagnostic procedures. Australian researchers must confirm legitimate research use at the time of purchase.

Tirzepatide is stocked in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, and 120mg vial strengths — the broadest range of any peptide in our Australian catalogue. All strengths supplied as lyophilised powder in 10-pack format for reproducible research protocols.

Refer to available product documentation for specific storage guidance. In general, lyophilised Tirzepatide should be stored in a freezer. After reconstitution, refrigerate and follow the usage timeframe in the product documentation. Protect vials from direct light and excessive moisture. Always follow your institution's laboratory handling protocols.

Tirzepatide is shipped lyophilised in discrete, temperature-protected packaging from our Australian warehouse. Orders are processed and dispatched within 1–3 business days of payment confirmation. Estimated delivery: 5–10 business days after dispatch. Free express shipping on orders over $500 AUD. Full email tracking provided upon dispatch.